戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  or by applying varying pressures during gel manufacture.
2  cells, which are difficult and expensive to manufacture.
3 ng, and walking long distances, but not tool manufacture.
4 in pharmaceutical research, development, and manufacturing.
5 nt) steel tailor-designed for laser additive manufacturing.
6  adequately explore its potential is textile manufacturing.
7 ompounds relevant in food chemistry and food manufacturing.
8 sugar and byproducts severely affect sucrose manufacturing.
9 ste CO(2) and to reduce pollution in polymer manufacturing.
10 complex activities, such as apparel or paper manufacturing.
11    The syntheses are amenable to large scale manufacturing.
12 ent semiconductor foundry protocols for chip manufacturing.
13 ed nanomaterial discovery, optimization, and manufacturing.
14 ns are expanding rapidly enabled by scalable manufacturing.
15 on prototypes that are realized via additive manufacturing.
16 render this reaction amenable to tonne-scale manufacturing.
17  waste and improve sustainability in polymer manufacturing.
18  to processing of nanomaterials and advanced manufacturing.
19  of surfactants and the complexity of device manufacturing.
20 broad utility of these catalysts in additive manufacturing.
21  for large-scale, automated cellular therapy manufacturing.
22 an example of selective single-domain device manufacturing.
23  sectors like aviation, heavy transport, and manufacturing.
24 means of an electric-field-assisted additive manufacturing.
25 g/storage to tissue engineering and additive manufacturing.
26 is to improve the sustainability of chemical manufacturing.
27 lation, analytical modelling, additive layer manufacturing (3D printing) and experimental testing are
28 luminium alloy in situ during laser additive manufacturing(9).
29 cal carbon dioxide (Sc-CO(2)) technology for manufacturing a "smart" biomaterial scaffold, which reta
30 ically, we show that of n = 167 tested LLINs manufactured after 2013, only 17% are fulfilling the req
31 noic acid (PFOA) was used as a fluoropolymer manufacturing aid at a fluoropolymer production facility
32 d by laser powder bed fusion (LPBF) additive manufacturing (AM) are being reported at a rapid rate, t
33                                     Additive manufacturing (AM) enables production of components that
34                                     Additive Manufacturing (AM) techniques offer shorter supply chain
35 cles for the widespread adoption of additive manufacturing (AM).
36 ic biology chassis that can be programmed to manufacture and deliver products safely without interfer
37 ife of (68)Ga (68 min) creates problems with manufacture and delivery.
38 emitting diodes (LEDs) owing to their facile manufacture and excellent optoelectronic performance, in
39               Combining the low cost of PMMA manufacture and flexible designs of TADF molecules, pure
40 ised by their propensity to aggregate during manufacture and storage.
41 nal integrity of therapeutic-proteins during manufacture and to screen for and identify both substand
42                    As a proof-of-concept, we manufactured and characterized the properties of non-ele
43 turized 3D-printed device has been designed, manufactured and validated to perform as a low-cost sens
44 iers identified on the demanding path toward manufacturing and adoption of tissue and organ replaceme
45 materials degradation, hindering large-scale manufacturing and applications of sulfide-based solid-st
46 ssing PfLSA1 and PfLSAP2 will now proceed to manufacturing and clinical assessment under good manufac
47                             The expansion of manufacturing and commercial agriculture alongside rapid
48 on path that is synergistic between additive manufacturing and dispersion strengthening, possibly ena
49 ant targets for increasing in vitro platelet manufacturing and for managing quantitative platelet dis
50  Despite using additional energy for machine manufacturing and fuel consumption, the mechanized pract
51 atform must enable rapid discovery, scalable manufacturing and global distribution.
52                       In conclusion, on-site manufacturing and infusion of non-cryopreserved LV20.19
53 sential in the development of strategies for manufacturing and maximizing the efficiency of pharmaceu
54  chemicals that are added to plastics during manufacturing and may leach out once they reach the envi
55 n batteries during materials selection, cell manufacturing and operation.
56                    A combination of feasible manufacturing and renewable modules can offer an attract
57 ther drug carrier systems, including ease of manufacturing and scale-up to industrial level, higher d
58 ign characteristics owing to advancements in manufacturing and surgical techniques.
59 eby report for the first time on the design, manufacturing and testing of a three-dimensional (3D) ne
60  of this material is instead scrapped during manufacturing and the remainder during fabrication of fi
61 eramic scaffolds were fabricated by additive manufacturing and then modified for pore-wall reinforcem
62  because of their ease of use, lower cost of manufacturing, and access to intracellular targets.
63  second part of this article, key chemistry, manufacturing, and controls (CMC) information is provide
64  database for scientific research, practical manufacturing, and engineering.
65 te element modeling, fabricated via additive manufacturing, and mechanically tested to determine the
66       Global supply networks in agriculture, manufacturing, and services are a defining feature of th
67  printing (3DP) has transformed engineering, manufacturing, and the use of advanced materials due to
68                        However, conventional manufacturing approaches are hampered by challenges with
69 cturing methods like multi-material additive manufacturing are enabling realization of multiscale mat
70 ale surface features, which are artifacts of manufacturing, are shown to influence the morphology of
71 ors (EHMRs), widely used in construction and manufacturing, as an alternative to N95 respirators duri
72 e extreme forces and deformation while being manufactured at large scales have remained a rare find.
73 rally selective properties, capable of being manufactured at scale.
74 ver, logistical complexity and high costs of manufacturing autologous viral products limit CAR T cell
75  a manufacturable structure, and (3) Digital manufacturing-automated manufacture of the compiled stru
76 CAR T cell product, including variability in manufacturing, availability, and toxicity profiles.
77  of legacy AFFF (3% application formulation, manufactured before 2001) was provided by the Massachuse
78 from 3 test labs, using whole slide scanners manufactured by 3 different vendors.
79 n Heptavalent (A,B,C,D,E,F,G)-(Equine) (BAT) manufactured by Emergent BioSolutions Canada Inc is an e
80 ciency of a 5.5 um thick MXene patch antenna manufactured by spray-coating from aqueous solution reac
81 o assess if the therapeutic efficacy of UDCA manufactured by the university hospital is equivalent to
82 0 mg tablets and capsules were developed and manufactured by the university hospital.
83 utions with Aroclors in most foods and found manufacturing byproduct PCBs, including PCB11, in tilapi
84 developed CRISPR adaptation-mediated library manufacturing (CALM), which turns bacterial cells into "
85  lymphoblastic leukemia blasts during CART19 manufacturing can lead to CAR19+ leukemic cells (CARB19)
86 control MPF formation throughout the textile manufacturing chain by using cutting methods which minim
87 tion has remained elusive due to significant manufacturing challenges.
88 e provide novel information on the impact of manufacturing changes on clinical outcomes and report on
89 er bed fusion (LPBF) is a method of additive manufacturing characterized by the rapid scanning of a h
90 ultilayer ceramic capacitors fabricated in a manufacturing-compatible process.
91 lexible materials and printing techniques to manufacture compliant and large-area electronics.
92 rcialized tools, with integrated device mass manufacturing cost still not at a competitive level for
93 g to their high photovoltaic efficiency, low manufacturing cost, and flexibility.
94 , ex vivo cellular manipulation, or cellular manufacture, could dramatically reduce costs and broaden
95                                     Additive manufacturing currently facilitates new avenues for mate
96 ctors can challenge the supply route used to manufacture d(9)-ivacaftor (17), requiring investigation
97      On the basis of their time patterns and manufacturing data, industrial contributions were found
98 g decreased bioefficacy of unused LLINs with manufacturing dates between 2013 and 2019 collected from
99   In contrast, all (100%, n = 25) LLINs with manufacturing dates prior to 2013 are meeting these bioe
100                                              Manufacturing delays resulted in early termination (376/
101 sence of motor vehicle traffic and suspended manufacturing during the coronavirus disease 2019 (COVID
102 re dissembling so that the materials used to manufacture each cartridge could be evaluated to determi
103 manufacturing to improve product quality and manufacturing efficiency.
104 gen display platforms and have launched cGMP manufacturing efforts to advance the SARS-CoV-2-RBD nano
105                     PD-1-edited T cells were manufactured ex vivo by cotransfection using electropora
106 o protein subunit vaccines, there is limited manufacturing expertise for these nucleic-acid-based mod
107          From 1980 to 2017, a fluorochemical manufacturing facility discharged wastewater containing
108 into the Cape Fear River by a fluorochemical manufacturing facility were detected in blood samples fr
109  of index cases.Conclusions: Evaluation of a manufacturing facility with a cluster of workers with re
110 of the apheresis product improved CAR T-cell manufacturing feasibility as well as heightened inflamma
111                                  KTE-X19 was manufactured for 71 patients and administered to 68.
112            Heart rate sensing smart bras are manufactured for females who participate in activity, ho
113 nano-materials are intensively developed and manufactured for potential biosensing and theranostic ap
114 rfaces, while considered a key to design and manufacturing for future applications, has hitherto been
115 icates a way forward for exploiting additive-manufacturing for realising polymer-based acoustic metam
116  fabricate high quality products by additive manufacturing (for example, 3D printing).
117 wealth of bone artefacts, including pendants manufactured from cave bear teeth that are reminiscent o
118                              The material is manufactured from commercial carbon fibers and a structu
119 tucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifi
120                    Four modern foldable lOLs manufactured from silicone and acrylic materials had sig
121 t occur during the various stages of textile manufacturing: from fiber extrusion to assembly of the f
122 l substrates, demonstrating the potential of manufacturing geometrically versatile devices based on n
123 opment processes to support the alignment of manufacturing, global policy, and program implementation
124              Widely present in nature and in manufactured goods, elastomers are network polymers typi
125 h efficiency, and that are suitable for mass-manufacture, have been elusive.
126             Here we report a novel method of manufacturing high-density multiplexed protein microarra
127 MA strategy has significant implications for manufacturing high-performance fibrous platforms to meet
128      These wearable devices require low-cost manufacturing, high reliability, multifunctionality and
129 ign regions in China are concentrated in key manufacturing hubs, including the Yangtze River Delta, P
130 y diversity inherent in human plasma used to manufacture IG products..
131 roposed designs, to determine the effects of manufacturing imperfections and to optimise the performa
132 ificant attention for advanced materials and manufacturing in this epochal transition.
133 ogeochemical cycles, play important roles in manufacturing industries and biomedical research, and in
134                               The process of manufacturing infant milk formulas (IMFs) involves heat
135 d synthetic biology approaches to design and manufacture innovative materials.
136           These aggregation chemicals can be manufactured into a lure that could be used to improve b
137  different PEDOT:PSS (0.0, 0.1, and 0.5 wt%) manufactured into hydrogel disks using the two methods w
138                               Laser additive manufacturing is attractive for the production of comple
139 n cost as little as 23 cents (US dollars) to manufacture, is portable (weighs 13 g and requires no el
140  vivo, antigen escape and heterogeneity, and manufacturing issues.
141                 Since the advent of additive manufacturing, known commonly as 3D printing, this techn
142 ing due to complex electronics requirements, manufacturing limitations, and the increase in viscous d
143 n toxicity caused by upstream extraction and manufacturing linked to technologies such as solar panel
144 iohybrid design offers the unique ability to manufacture materials and devices that match the dynamic
145 rtance to the ultimate quality of additively manufactured materials.
146 mounts of matter, for harvesting energy, for manufacturing materials and for sensing chemical and bio
147        Our approach offers a general way for manufacturing metal matrix composites with high overall
148 aser lithography, an emerging micro-additive manufacturing method with unique geometric capabilities
149              By using existing silicon-based manufacturing methodologies, this room-temperature gas s
150   Conventional antibody-drug conjugate (ADC) manufacturing methods are based on the nonselective bioc
151                                     Advanced manufacturing methods like multi-material additive manuf
152 led 3D mesostructures serve as the basis for manufacturing methods that can bypass limitations of con
153                                  By using 2D manufacturing methods we are able to create actuators th
154 ands, as well as the evolution of industrial manufacturing methods.
155 re impossible to achieve through traditional manufacturing methods.
156                                           We manufactured microfluidic devices with narrow channels (
157                                       Plants manufacture more than 3,000 THIQ alkaloids, including th
158 uccessfully through demonstrated and easy-to-manufacture NanoThermoMechanical logic gates.
159 ts successful application as monomer for the manufacture of bioplastics.
160 19, 344 patients underwent leukapheresis for manufacture of CAR(+) T cells (liso-cel), of whom 269 pa
161 he same lead components were employed in the manufacture of carbon-based inks.
162 f metal nanoparticles, as precursors for the manufacture of composite catalysts and those active in p
163  and enzymatic methods now available for the manufacture of custom proteins containing noncoded eleme
164                                          The manufacture of industrial PCBs was banned in 1978, but P
165 rial in biorefineries, or for the industrial manufacture of many diverse products, given their lignoc
166 ouplings) are essential to the discovery and manufacture of pharmaceuticals and agrochemicals(1,2).
167 o its stiffness and astringent taste, and in manufacture of products from jabuticaba fruit, it is res
168                                          The manufacture of sensors using large-scale production tech
169 an induce substantial toxic effects, and the manufacture of the cells is complex.
170 ure, and (3) Digital manufacturing-automated manufacture of the compiled structure.
171 t fascinate humanity, inspiring an unceasing manufacturing of a kaleidoscopic variety of dyes and pig
172 actices such as sandblasting denim jeans and manufacturing of artificial stone benchtops has led to r
173 in terms of bioprinting technologies for the manufacturing of cellular constructs with particular emp
174      3D printing can allow for the efficient manufacturing of elaborate structures difficult to reali
175                                     To guide manufacturing of electrode architectures, in-situ X-ray
176 fast prototyping and potentially large-scale manufacturing of functional devices.
177 ns using LLZO which may guide the design and manufacturing of high energy density solid-state batteri
178 is approach a promising route for the facile manufacturing of high-performance electrodes at large in
179 of bioinks have been developed, allowing the manufacturing of in vitro models and implants tested pre
180 rning method provides a new way for additive manufacturing of integrated optoelectronic devices using
181                  The 3D printing allows easy manufacturing of MALDI targets with different dimensions
182 egacy chemicals used in firefighting and the manufacturing of many industrial and consumer goods, are
183  and multilayered structures, and integrated manufacturing of materials for coupled mechanical and fu
184 layers during processing is critical for the manufacturing of optoelectronics.
185 utomated fast-flow instrument for the direct manufacturing of peptide chains up to 164 amino acids lo
186 duction attributes and is currently used for manufacturing of several therapeutic proteins and viral
187 applications include material processing and manufacturing of small and large engineering components
188        T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise con
189 pendent electrical signal input, the present manufacturing of the array limited the number of effecti
190  with the vast amount of generated data, and manufacturing of the electrode array itself.
191                            However, scalable manufacturing of the required complex micromaterials rem
192 on is prolific as a result of the widespread manufacturing of these compounds and their chemical pers
193 gration unlocks the potential of large-scale manufacturing of these integrated systems with low cost
194 s of processing - pasteurization and yoghurt manufacturing - on some health-promoting lipidome compon
195 sufficient to use the recovered lactose from manufacturing operations.
196  where often molten wax is used; in additive manufacturing or metal-production processes; or in extre
197 th the potential to transform medical device manufacturing, organ replacement, and the treatment of d
198 eating engineered artificial organelles that manufacture organic compounds intracellularly.
199 academia; contract research, development and manufacturing organizations; and the pharmaceutical indu
200 ing for prototyping, to mimic conventionally manufactured outputs, toward integrated approaches from
201 ee-dimensional (3D) printing is transforming manufacturing paradigms within healthcare.
202             To advance the considerations on manufacturing parameter dominance, both study design and
203  quality and low repeatability of additively manufactured parts are key technological obstacles for t
204 sin-based cleavage reaction is necessary for manufacturing peptides using rDNA technology with tandem
205                                     Additive manufacturing permits innovative soft device architectur
206 emical variability can present challenges to manufacturing personalized cancer vaccines in an optimal
207 ucose to fructose is a critical step towards manufacturing petroleum-free chemicals from lignocellulo
208 cterization of materials, quality control of manufactured plastic parts, self-assembly of objects in
209              Electrospinning is an appealing manufacturing platform for GDIs, as it allows for incorp
210 ps that are not directly scalable to current manufacturing platforms.
211 pendent lots of clinical material under good manufacturing practice (GMP) conditions.
212 facturing and clinical assessment under good manufacturing practice (GMP) guidelines.
213 d MSCs) is produced using an optimized, good manufacturing practice (GMP)-compliant manufacturing pro
214    Following in vitro expansion using a good manufacturing practice-compliant methodology (designed t
215 erapies that could be integrated into a good manufacturing practice-compliant process.
216     All procedures were performed under good manufacture practices using solely xeno-free reagents.
217 erview of this complex field of current good manufacturing practices (cGMP) based on biopharmaceutica
218  blood or leukapheresis, expanded under good manufacturing practices (GMP) conditions, and administer
219 C) closer to a possible validation in a Good Manufacturing Practices (GMP) environment.
220 t and reliable monitoring of PTMs during the manufacturing process for both bioreactor control or as
221 aquinone were determined at each step of the manufacturing process for green and black tea using gas
222  during the directed energy deposition (DED) manufacturing process of a 7075-Al alloy part.
223 f parameters in the formulation composition, manufacturing process, and characterization of micropart
224  good manufacturing practice (GMP)-compliant manufacturing process.
225 acterization and close monitoring during the manufacturing process.
226 us variables involved in the composition and manufacturing process.
227 that are fast, applicable in situ and to the manufacturing process.
228 ation of the formulation composition and the manufacturing process.
229                 Excellent reliability of the manufacturing processes and low cost have drawn ever inc
230   The composition of the formulation and the manufacturing processes determine the essential property
231                                     Additive manufacturing processes used to create regenerative bone
232                    Products, feedstocks, and manufacturing processes will need to integrate the princ
233  and new drug products leading to continuous manufacturing processes, and personalized medicine.
234 orm further evaluation of product design and manufacturing processes, including quantification of met
235 ation-hardened alloys and different additive manufacturing processes.
236 he extensive experience regarding industrial manufacturing processes.
237 reduced productivity in therapeutic antibody manufacturing processes.
238 baseline metrics for current oligonucleotide manufacturing processes.
239                                     Additive manufacturing promises a major transformation of the pro
240           Ethyl alcohol content in the beers manufactured ranged from 0.41%v/v in traditional non-alc
241 ce our modifications do not impose intricate manufacturing, require long post-processing, nor sacrifi
242 ly as well as externally controlled tools to manufacture reticular materials over all the length scal
243                             Using additively manufactured rock, we demonstrate that highly conductive
244        In addition, the established clinical manufacturing, safety and efficacy of blank sHDL nanopar
245 cal polishing (CMP), an essential process to manufacture semiconductor wafers.
246 nsport, and materials, a 50-52% reduction in manufacturing, services, and buildings, and a 39% reduct
247 esults are an important advance towards mass-manufactured, silicon-based, functional robots that are
248 P receiving wastewater from a pharmaceutical manufacturing site, (i) 10 times as many potential indus
249                    The second approach is to manufacture small-scale tensile specimens containing onl
250  logistical challenges in material sourcing, manufacturing, standardization and transportation.
251 alyzed to study the effect of aging time and manufacturing steps (filtration, addition of additives o
252 annot be removed in the subsequent chocolate-manufacturing steps.
253  and ongoing technical challenges related to manufacturing, storage, transport, and external noninvas
254 autologous cell replacement to be effective, manufacturing strategies will need to change.
255 es of these undercut MNAs and the associated manufacturing strategy, which is compatible with diverse
256 incorporate metals within the materials they manufacture, such as protective armor and teeth.
257                                           By manufacturing sufficiently smaller pores, each tRNA is r
258     The aim of this study is to describe the manufacturing technique and to assess the preliminary re
259 l, this work establishes a scalable additive manufacturing technique that enables the integration of
260   3D printing technology has become a mature manufacturing technique, widely used for its advantages
261 sed deposition modeling (FDM) based additive manufacturing technique.
262 of the design and integration strategies and manufacturing techniques for such sensing systems is giv
263  Three-dimensional bioprinting uses additive manufacturing techniques for the automated fabrication o
264                             Lately, additive manufacturing techniques have made a number of designs w
265 nowires are beyond the capability of current manufacturing techniques, which impose limitations on th
266 lumes that stem from limitations in additive manufacturing techniques.
267  thus limiting their processing via additive manufacturing techniques.
268 ue advantages that they and their associated manufacturing technologies have offered.
269 al biosensors constructed with semiconductor manufacturing technology (SMT)-produced electrodes and a
270       Over the last decades, advancements in manufacturing technology, computational tools, and synth
271 extiles, utilizing a fundamentally different manufacturing technology.
272 r developing the next generation of additive manufacturing technology.
273 ) partition among indoor reservoirs in (1) a manufactured test house under controlled conditions (HOM
274   With the industrialisation of nanoparticle manufacture, the pervasive incursion of nanoparticles in
275 S-CoV-2 from VTM samples using an additively manufactured three-dimensional cartridge and a smartphon
276 printing, and the large build space provides manufacturing throughput, while FFF offers a great selec
277 ith the microstructure evolved in additively manufactured Ti6Al4V alloy.
278 c (BioCer) implants consisting of additively manufactured titanium frames enveloped with CaP BioCer o
279                              Primary NPs are manufactured to be that size, while secondary NPs origin
280 and modified by either bottom-up or top-down manufacturing to enable different functions for water fi
281 ithography is currently entering high-volume manufacturing to enable the continued miniaturization of
282  microstructure, paving the way for additive manufacturing to repair, restore, and reshape any supera
283 al reduced the PBC treatment costs using the manufactured UDCA by the university hospital.
284  reduced 66.1% the PBC treatment costs using manufactured UDCA.
285 vice designed through bioscanner imaging and manufactured using 3D printing for use with negative pre
286                                The iDES were manufactured using a hot melt extrusion process with acc
287                                  The BTS was manufactured using a terpolymer comprising poly p-dioxan
288                                    PHPI were manufactured using standardized processes.
289  the realization of an exemplary sensor chip manufactured using the United Monolithic Semiconductor (
290  we show the potential for "Li-free" battery manufacturing using the Li(7)La(3)Zr(2)O(12) (LLZO) elec
291                          Volumetric additive manufacturing (VAM) forms complete 3D objects in a singl
292                                         Cell manufacturing was set at 14 d with the goal of infusing
293               Deep decarbonization of cement manufacturing will require remediation of both the CO(2)
294 aterials used in food packaging are commonly manufactured with a polyurethane adhesive layer in its s
295 -lumen, nano-structured glaucoma shunts were manufactured with or without a degradable inner core des
296                      In particular, additive manufacturing with two-photon polymerization allows crea
297 fect of these minority phases was avoided by manufacturing, with the help of focused-ion-beam, a mum-
298 hanically-strong biomaterial combined during manufacturing would replace injectable defect fillers (c
299 t metal 3D printers promise to revolutionize manufacturing, yet they have not reached optimal operati
300 apita, recycling rate, product lifespan, and manufacturing yield) in a dynamic material flow analysis

 
Page Top